Subscribe
Sign in
Home
Who is Alex Kesin?!
Silly Posts
Archive
Latest
Top
Discussions
The Pageant of Responsible Longevity
On the quiet horror of healthspan science and its desperate decorum
Apr 26
•
Alex Kesin
2
Share this post
Alex Kesin's Pharmacopoeia
The Pageant of Responsible Longevity
Copy link
Facebook
Email
Notes
More
2
Monologues for Molecules
A not-so-casual reminder that your molecule isn’t a molecule—it’s a movie pitch.
Apr 21
•
Alex Kesin
6
Share this post
Alex Kesin's Pharmacopoeia
Monologues for Molecules
Copy link
Facebook
Email
Notes
More
Charles River Is In Trouble
Their moat is made of dead animals – but now the rats are leaving. Can Charles River take the hit?
Apr 16
•
Alex Kesin
4
Share this post
Alex Kesin's Pharmacopoeia
Charles River Is In Trouble
Copy link
Facebook
Email
Notes
More
What Skiing Really Means in San Francisco
[leans in, lowers voice to a conspiratorial whisper]
Apr 13
•
Alex Kesin
2
Share this post
Alex Kesin's Pharmacopoeia
What Skiing Really Means in San Francisco
Copy link
Facebook
Email
Notes
More
The Mice Will See You Now: FDA’s Roadmap to Stop Requiring Animal Testing Eventually If You Ask Nicely and Say Please
(Kind of, eventually, maybe)
Apr 11
•
Alex Kesin
7
Share this post
Alex Kesin's Pharmacopoeia
The Mice Will See You Now: FDA’s Roadmap to Stop Requiring Animal Testing Eventually If You Ask Nicely and Say Please
Copy link
Facebook
Email
Notes
More
1
March 2025
Does the NIH Still Work?
Legacy, lethargy, and the urgent case for reinvention
Mar 30
•
Alex Kesin
6
Share this post
Alex Kesin's Pharmacopoeia
Does the NIH Still Work?
Copy link
Facebook
Email
Notes
More
February 2025
China’s leap in pharma: slow and fast trends behind its rise
Introduction
Feb 21
•
Alex Kesin
3
Share this post
Alex Kesin's Pharmacopoeia
China’s leap in pharma: slow and fast trends behind its rise
Copy link
Facebook
Email
Notes
More
6 ways the new FDA can turbocharge drug development
Proposal 1.
Feb 9
•
Alex Kesin
Share this post
Alex Kesin's Pharmacopoeia
6 ways the new FDA can turbocharge drug development
Copy link
Facebook
Email
Notes
More
Narrow Leverage: How Small Strengths Create Big Power
If you have uniquely powerful but “narrow” leverage in a given domain, you can amplify and transfer it asymmetrically to gain influence beyond your…
Feb 7
•
Alex Kesin
Share this post
Alex Kesin's Pharmacopoeia
Narrow Leverage: How Small Strengths Create Big Power
Copy link
Facebook
Email
Notes
More
January 2025
Prescription strength: musings about the past/present/future of sarcopenia therapeutics
Table of Contents
Jan 9
•
Alex Kesin
Share this post
Alex Kesin's Pharmacopoeia
Prescription strength: musings about the past/present/future of sarcopenia therapeutics
May contain explicit content
This post was automatically hidden by your content settings.
Show anyway
Adjust settings
Copy link
Facebook
Email
Notes
More
August 2024
Links (3)
1) TIL that Calico has advanced a sister molecule of ISRIB into clinical trials for ALS
Aug 9, 2024
•
Alex Kesin
Share this post
Alex Kesin's Pharmacopoeia
Links (3)
Copy link
Facebook
Email
Notes
More
July 2024
Links (2)
Dopamine.
Jul 19, 2024
•
Alex Kesin
Share this post
Alex Kesin's Pharmacopoeia
Links (2)
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts